| Drug Type Live biotherapeutic products | 
| Synonyms | 
| Target- | 
| Action modulators | 
| Mechanism Bacteria replacements, Microbiome modulators | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePhase 2 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Enterocolitis | Phase 2 | - | - | |
| Enterocolitis, Necrotizing | Phase 1 | United States  | 30 Jan 2014 | |
| Extremely low birth weight infant | Phase 1 | United States  | 30 Jan 2014 | 





